查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612747

犬异位性皮肤炎市场：按产品、过敏原、给药途径、分销管道和最终用户 - 2025-2030 年全球预测

Canine Atopic Dermatitis Market by Product (Antihistamines, Glucocorticoids, Immunosuppressants), Allergen (Dander, Microorganisms, Mites), Route of Administration, Distribution Channel, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年犬异位性皮肤炎市值为15.7亿美元，预计到2024年将达到16.9亿美元，复合年增长率为8.40%，到2030年将达到27.6亿美元。

犬异位性皮肤炎（CAD）是犬类常见的过敏性疾病，其特征是过敏原引起的皮肤发炎。宠物拥有量的增加和宠物健康意识的提高凸显了对有效 CAD 治疗的需求，从而推动了对创新治疗的需求。 CAD 治疗的应用范围从提供专业皮肤科服务的兽医诊所到含有抗组织胺药物和免疫抑制剂的家庭护理产品。最终用途范围主要包括宠物饲主和兽医专业人士寻求增强的治疗方案以改善宠物的福利并减轻症状。市场成长主要是由生物技术和製药的进步、研发投资的增加以及提供更有效且副作用更少的标靶治疗的新产品的推出所推动的。此外，宠物过敏的盛行率不断上升，以及宠物饲主将宠物视为家庭成员的人性化，正在为高成本治疗解决方案创造机会。然而，挑战包括严格的监管核准、长期用药的潜在副作用以及创新治疗方法的高成本。其他障碍包括宠物对治疗的不同反应以及需要更好地了解 CAD 的遗传和环境触发因素。主要市场开拓包括开发新型生技药品、根据个别宠物的需求量身定制治疗的个人化医疗方法，以及能够早期准确识别 CAD 的创新诊断工具。创新领域专注于整合资料分析和人工智慧驱动的平台，以预测过敏模式并客製化预防措施。随着公司努力满足未满足的消费者需求并扩大 CAD 的治疗选择，市场正在向非侵入性治疗、营养食品和益生菌解决方案转变，这表明它具有广阔的未来性。对于寻求在竞争环境中实现成长和广泛采用的公司来说，平衡有效性和可负担性至关重要。

主要市场统计
基准年[2023] 15.7亿美元
预测年份 [2024] 16.9亿美元
预测年份 [2030] 27.6亿美元
复合年增长率（%） 8.40%

市场动态：快速发展的犬异位性皮肤炎市场的关键市场洞察

供需的动态交互作用正在改变犬特应性皮肤炎市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 宠物数量增加，狗过敏原污染增加
    • 越来越关注天然成分或非药物方法
  • 市场限制因素
    • 宠物仿单标示外用药增加
  • 市场机会
    • 由于犬异位性皮肤炎 (CAD) 的研发投资，产品推出量增加
    • 对宠物保险的持续需求和饲主日益增长的兴趣
  • 市场挑战
    • 对 CAD 复杂病因及其治疗效果和安全性的担忧

波特的五力：驾驭犬异位性皮肤炎市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对犬异位性皮肤炎市场的影响

外部宏观环境因素在塑造犬异位性皮肤炎市场的表现动态中发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析了解犬异位性皮肤炎市场的竞争状况

犬异位性皮肤炎市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵供应商在犬异位性皮肤炎市场的绩效评估

FPNV定位矩阵是评估犬异位性皮肤炎市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製犬异位性皮肤炎市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对犬特应性皮肤炎市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 宠物数量增加以及与狗过敏原相关的污染增加
      • 更重视天然成分和非药物方法
    • 抑制因素
      • 宠物使用仿单标示外药物的情况增加
    • 机会
      • 增加犬异位性皮肤炎（CAD）产品的研发投资
      • 对宠物保险的持续需求和宠物主人日益增长的担忧
    • 任务
      • 对 CAD 复杂病因以及治疗有效性和安全性的担忧
  • 市场区隔分析
    • 产品：扩大抗组织胺和糖皮质激素的使用，有效治疗 CAD
    • 过敏原：尘螨和微小寄生虫是 CAD 的主要原因
    • 给药途径：注射和口服是最优选的给药方法。
    • 分销管道：透过线上分销管道提高 CAD 药物的供应
    • 最终使用者：CAD 诊断的增加和对临床有效治疗的需求
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章犬异位性皮肤炎市场：副产品

  • 抗组织胺药
  • 糖皮质激素
  • 免疫抑制剂
  • 单株抗体

第七章犬异位性皮肤炎市场过敏原

  • 头皮
  • 微生物
  • 打钩
  • 花粉

第八章犬异位性皮肤炎市场：依给药途径

  • 可注射的
  • 口服
  • 话题

第九章犬异位性皮肤炎市场：按分销管道

  • 医院/诊所
  • 在线的
  • 零售兽医

第 10 章犬异位性皮肤炎市场：依最终用户分类

  • 医院
  • 兽医诊所

第十一章 北美和南美犬异位性皮肤炎市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区犬异位性皮肤炎市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲犬异位性皮肤炎市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 硕腾在美国内布拉斯加州林肯市开设最先进的工厂
    • Zoetis 宣布 FDA核准Apoquel 咀嚼片（Oclacitinib 咀嚼片）用于抑制与过敏性皮肤炎和异位性皮肤炎相关的犬痒症
    • ILC Therapeutics 与 Decla Pharmaceuticals 建立策略研发合作伙伴关係
    • Bioiberica 使用基于脂质的生物圈成分推出用于治疗异位性皮肤炎的狗和猫项圈
    • 皇家犬北美公司宣布推出 SKINTOPIC 来帮助治疗犬异位性皮肤炎
  • 战略分析和建议

公司名单

  • AB Science SA
  • AbbVie, Inc.
  • Agrolabo SpA
  • Bimeda, Inc.
  • Bioceltix JSC
  • Bioiberica SAU
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Deep Marine Collagen
  • Elanco Animal Health Incorporated
  • Farnam Companies, Inc.
  • IDEXX Laboratories, Inc.
  • Incyte Corporation
  • Kemin Industries, Inc.
  • LEO Pharma A/S
  • Merck & Co. Inc.
  • Natural Dog Company
  • Nextmune
  • Nippon Zenyaku Kogyo Co., Ltd.
  • Novartis AG
  • Ourofino Animal Health
  • Pfizer Inc
  • Phibro Animal Health Corporation
  • Regeneron Pharmaceuticals, Inc
  • Saiba Animal Health AG
  • Toray Industries Inc.
  • Vetoquinol SA
  • Virbac Corporation
  • Zinpro Corporation
  • Zoetis Inc.
  • Zymox by Pet King Brands LLC
Product Code: MRR-A339DAEFA20E

The Canine Atopic Dermatitis Market was valued at USD 1.57 billion in 2023, expected to reach USD 1.69 billion in 2024, and is projected to grow at a CAGR of 8.40%, to USD 2.76 billion by 2030.

Canine Atopic Dermatitis (CAD) is a prevalent allergic condition in dogs characterized by inflammation of the skin due to allergens. The necessity for effective CAD treatment is underscored by the growing pet ownership and heightened awareness about pet health, which pushes demand for innovative therapies. The application of CAD treatments spans from veterinary clinics offering specialized dermatological services to home-care products incorporating antihistamines and immunosuppressant formulations. The end-use scope primarily involves pet owners and veterinary professionals seeking enhanced treatment options to improve pet welfare and alleviate symptoms. Market growth is significantly driven by the advancement of biotech and pharmaceutical products, increased R&D investments, and new product launches that offer more effective, targeted therapies with fewer side effects. Additionally, the rising prevalence of pet allergies and the humanization of pets-where pet owners increasingly treat pets as part of the family-create opportunities for premium-priced therapeutic solutions. However, limitations such as stringent regulatory approvals, potential side effects of long-term medication use, and the high cost of innovative treatments present challenges. Additional hurdles include the variability in pet response to treatment and a need for greater understanding of CAD's genetic and environmental triggers. Key potential opportunities in the market exist in developing novel biologics, personalized medicine approaches that tailor treatments to individual pet needs, and revolutionary diagnostic tools that enable early and accurate identification of CAD. Innovation areas focus on integrating data analytics and AI-driven platforms to predict allergy patterns and customize preventive measures. The market is dynamic, with a shift towards non-invasive treatments, nutraceuticals, and probiotic solutions, suggesting a future rich with potential as companies strive to address unmet consumer needs and expand the therapeutic arsenal against CAD. Balancing efficacy and affordability will be crucial for companies looking to capture growth and ensure broad adoption in a competitive landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 1.57 billion
Estimated Year [2024] USD 1.69 billion
Forecast Year [2030] USD 2.76 billion
CAGR (%) 8.40%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Canine Atopic Dermatitis Market

The Canine Atopic Dermatitis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of pet ownership and rising pollution related to allergens on dogs
    • Rising focus on natural ingredients or non-pharmacological methods
  • Market Restraints
    • Increasing use of off-label drugs among pets
  • Market Opportunities
    • Rise in the R&D investments product launches for canine atopic dermatitis (CAD)
    • Ongoing demand for pet insurance and rising concerns among pet owners
  • Market Challenges
    • Complex etiology of CAD & concerns over treatment efficacy and safety

Porter's Five Forces: A Strategic Tool for Navigating the Canine Atopic Dermatitis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Canine Atopic Dermatitis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Canine Atopic Dermatitis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Canine Atopic Dermatitis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Canine Atopic Dermatitis Market

A detailed market share analysis in the Canine Atopic Dermatitis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Canine Atopic Dermatitis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Canine Atopic Dermatitis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Canine Atopic Dermatitis Market

A strategic analysis of the Canine Atopic Dermatitis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Canine Atopic Dermatitis Market, highlighting leading vendors and their innovative profiles. These include AB Science SA, AbbVie, Inc., Agrolabo SpA, Bimeda, Inc., Bioceltix JSC, Bioiberica S.A.U., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Deep Marine Collagen, Elanco Animal Health Incorporated, Farnam Companies, Inc., IDEXX Laboratories, Inc., Incyte Corporation, Kemin Industries, Inc., LEO Pharma A/S, Merck & Co. Inc., Natural Dog Company, Nextmune, Nippon Zenyaku Kogyo Co., Ltd., Novartis AG, Ourofino Animal Health, Pfizer Inc, Phibro Animal Health Corporation, Regeneron Pharmaceuticals, Inc, Saiba Animal Health AG, Toray Industries Inc., Vetoquinol S.A., Virbac Corporation, Zinpro Corporation, Zoetis Inc., and Zymox by Pet King Brands LLC.

Market Segmentation & Coverage

This research report categorizes the Canine Atopic Dermatitis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Antihistamines, Glucocorticoids, Immunosuppressants, and Monoclonal Antibodies.
  • Based on Allergen, market is studied across Dander, Microorganisms, Mites, and Pollen.
  • Based on Route of Administration, market is studied across Injectable, Oral, and Topical.
  • Based on Distribution Channel, market is studied across Hospitals & Clinics, Online, and Retail Veterinary.
  • Based on End-User, market is studied across Hospitals and Veternary Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of pet ownership and rising pollution related to allergens on dogs
      • 5.1.1.2. Rising focus on natural ingredients or non-pharmacological methods
    • 5.1.2. Restraints
      • 5.1.2.1. Increasing use of off-label drugs among pets
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise in the R&D investments product launches for canine atopic dermatitis (CAD)
      • 5.1.3.2. Ongoing demand for pet insurance and rising concerns among pet owners
    • 5.1.4. Challenges
      • 5.1.4.1. Complex etiology of CAD & concerns over treatment efficacy and safety
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Expanding use of antihistamines and glucocorticoids for effective treatment of CAD
    • 5.2.2. Allergen: Dust mites and microscopic parasites prevail as the major cause of CAD
    • 5.2.3. Route of Administration: Injectables and orals to be the most preferred mode of medication application
    • 5.2.4. Distribution Channel: Emerging availability of CAD medications through online distribution channels
    • 5.2.5. End-User: Increasing CAD diagnosis in clinics and need for effective treatments
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Canine Atopic Dermatitis Market, by Product

  • 6.1. Introduction
  • 6.2. Antihistamines
  • 6.3. Glucocorticoids
  • 6.4. Immunosuppressants
  • 6.5. Monoclonal Antibodies

7. Canine Atopic Dermatitis Market, by Allergen

  • 7.1. Introduction
  • 7.2. Dander
  • 7.3. Microorganisms
  • 7.4. Mites
  • 7.5. Pollen

8. Canine Atopic Dermatitis Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Injectable
  • 8.3. Oral
  • 8.4. Topical

9. Canine Atopic Dermatitis Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospitals & Clinics
  • 9.3. Online
  • 9.4. Retail Veterinary

10. Canine Atopic Dermatitis Market, by End-User

  • 10.1. Introduction
  • 10.2. Hospitals
  • 10.3. Veternary Clinics

11. Americas Canine Atopic Dermatitis Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Canine Atopic Dermatitis Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Canine Atopic Dermatitis Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Zoetis Opens New State-of-the-Art Facility in Lincoln, NE, USA
    • 14.3.2. Zoetis Announces FDA Approval of Apoquel Chewable (oclacitinib chewable tablet) for Control of Pruritus Associated With Allergic Dermatitis and Control of Atopic Dermatitis in Dogs
    • 14.3.3. ILC Therapeutics entered into a strategic R&D partnership with Dechra Pharmaceuticals
    • 14.3.4. Bioiberica Launches Dog And Cat Collar For Atopic Dermatitis Featuring Company's Lipids-Based Biosfeen Ingredient
    • 14.3.5. Royal Canin North America Announces Launch of SKINTOPIC to Help in the Management of Canine Atopic Dermatitis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AB Science SA
  • 2. AbbVie, Inc.
  • 3. Agrolabo SpA
  • 4. Bimeda, Inc.
  • 5. Bioceltix JSC
  • 6. Bioiberica S.A.U.
  • 7. Boehringer Ingelheim International GmbH
  • 8. Ceva Sante Animale
  • 9. Dechra Pharmaceuticals PLC
  • 10. Deep Marine Collagen
  • 11. Elanco Animal Health Incorporated
  • 12. Farnam Companies, Inc.
  • 13. IDEXX Laboratories, Inc.
  • 14. Incyte Corporation
  • 15. Kemin Industries, Inc.
  • 16. LEO Pharma A/S
  • 17. Merck & Co. Inc.
  • 18. Natural Dog Company
  • 19. Nextmune
  • 20. Nippon Zenyaku Kogyo Co., Ltd.
  • 21. Novartis AG
  • 22. Ourofino Animal Health
  • 23. Pfizer Inc
  • 24. Phibro Animal Health Corporation
  • 25. Regeneron Pharmaceuticals, Inc
  • 26. Saiba Animal Health AG
  • 27. Toray Industries Inc.
  • 28. Vetoquinol S.A.
  • 29. Virbac Corporation
  • 30. Zinpro Corporation
  • 31. Zoetis Inc.
  • 32. Zymox by Pet King Brands LLC

LIST OF FIGURES

  • FIGURE 1. CANINE ATOPIC DERMATITIS MARKET RESEARCH PROCESS
  • FIGURE 2. CANINE ATOPIC DERMATITIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CANINE ATOPIC DERMATITIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CANINE ATOPIC DERMATITIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CANINE ATOPIC DERMATITIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CANINE ATOPIC DERMATITIS MARKET DYNAMICS
  • TABLE 7. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DANDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY MICROORGANISMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY MITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY POLLEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY RETAIL VETERINARY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY VETERNARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. CANINE ATOPIC DERMATITIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. CANINE ATOPIC DERMATITIS MARKET, FPNV POSITIONING MATRIX, 2023